Yamabe N - Search Results

1

The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model.

Yokozawa T, Kim HJ, Yamabe N, Okamoto T, Cho EJ. Yokozawa T, et al. Among authors: yamabe n. J Pharm Pharmacol. 2007 Sep;59(9):1271-8. doi: 10.1211/jpp.59.9.0012. J Pharm Pharmacol. 2007. PMID: 17883899

2

Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress.

Kim HY, Yokozawa T, Cho EJ, Yamabe N. Kim HY, et al. Among authors: yamabe n. J Pharm Pharmacol. 2004 Oct;56(10):1299-305. doi: 10.1211/0022357044490. J Pharm Pharmacol. 2004. PMID: 15482645

3

Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.

Nakagawa T, Yokozawa T, Yamabe N, Rhyn DY, Goto H, Shimada Y, Shibahara N. Nakagawa T, et al. Among authors: yamabe n. J Pharm Pharmacol. 2005 Sep;57(9):1205-12. doi: 10.1211/jpp.57.9.0016. J Pharm Pharmacol. 2005. PMID: 16105242

4

Protective effect of Hachimi-jio-gan against renal failure in a subtotal nephrectomy rat model.

Yamabe N, Yokozawa T, Kim HY, Cho EJ. Yamabe N, et al. J Pharm Pharmacol. 2005 Dec;57(12):1637-44. doi: 10.1211/jpp.57.12.0014. J Pharm Pharmacol. 2005. PMID: 16354408

5

Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.

Yamabe N, Yokozawa T. Yamabe N, et al. J Pharm Pharmacol. 2006 Apr;58(4):535-45. doi: 10.1211/jpp.58.4.0014. J Pharm Pharmacol. 2006. PMID: 16597372

6

Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies.

Kang KS, Yamabe N, Kim HY, Yokozawa T. Kang KS, et al. Among authors: yamabe n. J Pharm Pharmacol. 2008 Apr;60(4):445-52. doi: 10.1211/jpp.60.4.0006. J Pharm Pharmacol. 2008. PMID: 18380916

7

Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats.

Kang KS, Yamabe N, Kim HY, Park JH, Yokozawa T. Kang KS, et al. Among authors: yamabe n. Eur J Pharmacol. 2008 Sep 4;591(1-3):266-72. doi: 10.1016/j.ejphar.2008.06.077. Epub 2008 Jun 27. Eur J Pharmacol. 2008. PMID: 18611400

8

Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.

Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T. Yamabe N, et al. J Ethnopharmacol. 2010 Jun 16;129(3):299-305. doi: 10.1016/j.jep.2010.03.032. Epub 2010 Apr 2. J Ethnopharmacol. 2010. PMID: 20363309

9

Kangen-karyu improves memory deficit caused by aging through normalization of neuro-plasticity-related signaling system and VEGF system in the brain.

Zhao Q, Yokozawa T, Yamabe N, Tsuneyama K, Li X, Matsumoto K. Zhao Q, et al. Among authors: yamabe n. J Ethnopharmacol. 2010 Sep 15;131(2):377-85. doi: 10.1016/j.jep.2010.07.016. Epub 2010 Jul 14. J Ethnopharmacol. 2010. PMID: 20637274

10

Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.

Yamabe N, Noh JS, Park CH, Kang KS, Shibahara N, Tanaka T, Yokozawa T. Yamabe N, et al. Eur J Pharmacol. 2010 Dec 1;648(1-3):179-87. doi: 10.1016/j.ejphar.2010.08.044. Epub 2010 Sep 15. Eur J Pharmacol. 2010. PMID: 20826139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters